Opinion

The European Medicines Agency (EMA) has confirmed that the UNICOM’s DADI (Digital Application Dataset Integration) project will now serve as a ‘Plan B’ for the implementation of regulatory data submissions. Amplexor’s Renato Rjavec looks at the opportunities and challenges this presents for pharma companies. A more data-driven way of managing regulated product data, based on […]

Open Cell, a ‘hotel for scientists’ in London, UK, provides a cluster of small labs within a large shipping container facility, that are available for short-term rental by biotech startups with a range of shared services and facilities. As well as private labs, the facilities provide access to equipment worth millions of pounds for just […]

At the end of last month, DDW’s Megan Thomas attended ELRIG’s Research & Innovation 2022: Innovations for Tomorrow’s Drug Discovery, at The King’s Centre in Oxford, UK. The four sessions addressed aspects of innovation across drug discovery and placed an emphasis on both the digital age and novel modalities: Omics technology innovations; The future of […]

Following the launch of Protas, an organisation which was launched on January 24, 2022, DDW Editorial Assistant Megan Thomas interviews Protas Chief Executive, Professor Sir Martin Landray, an epidemiologist and physician who has over 20 years’ experience of leading large, randomised clinical trials and has most recently been leading the landmark RECOVERY clinical trial into […]

Dr Anton Yuryev, Professional Services Director at  Elsevier explores how a project utilising artificial intelligence is helping discover drugs for a rare type of cancer.  Artificial Intelligence (AI) has considerable potential in the life sciences and healthcare sectors, where it is increasingly contributing to R&D breakthroughs. With its capacity to reduce the time spent processing data, improve […]

Hettie Stroebel, Founder and CEO of Launch Excellence looks at how target product profiles can be used by life sciences companies as a strategy for more effective product development.    The global effort to develop and distribute a SARS-CoV-2 vaccine in months is a triumph for the pharmaceutical industry. It is also unprecedented. Never in the […]

James Tyrrell, Chair, Global Health, APCO Worldwide, assesses the pharmaceutical industry’s response to the Russian invasion of Ukraine and its ramifications on the sector.     With no quick end to Russia’s invasion of Ukraine, life sciences companies are increasingly being challenged to navigate this complex geopolitical crisis. Pharma and medtech companies’ products are not bound […]

Dr. Tom Knapman, Director of Strategic Brand at SCIEX, explains how bioconvergent advances will help to drive key health trends in the coming year. As we move into 2022, we will see more and more advances in bioconvergence – biological, physical, and computing technologies inspired by nature. We expect these top five trends to exemplify […]

The theme for International Women’s Day 2022 is ‘Break the Bias’, in which society is encouraged to celebrate women’s achievements, in turn raising awareness against bias and inspiring positive action for equality. Though the initiative is interdisciplinary, the drug discovery, life science and pharmaceutical world boasts many achievements of this nature. DDW’s Megan Thomas has […]